Chicago, Jan. 05, 2026 (GLOBE NEWSWIRE) -- The global chitosan market valuation was valued at US$ 2.8 billion in 2025 and is projected to reach US$ 8.6 billion by 2035, growing at a CAGR of 11.8% from 2026 to 2035.
Global manufacturing output of Chitosan hit a record 38,000 metric tons in 2024. Wherein, industrial-grade volume led production with 18,500 metric tons while food-grade supplies reached 10,200 metric tons. In addition, pharmaceutical-grade material also saw growth hitting 9,400 metric tons. Such volumes rely on 130 processing facilities currently operating across Japan, China, and South Korea. Manufacturers are scaling up operations to support the expanding Chitosan market. High-volume output ensures downstream industries have consistent access to necessary inputs.
Request Sample Pages: https://www.astuteanalytica.com/request-sample/chitosan-market
Infrastructure investments further bolster supply chain resilience. For instance, SUEZ completed joint venture facilities in China during early 2024 boasting 30,000 tons of plastic waste sorting capacity annually. Cuantec launched a new Scottish production facility in May 2024 to serve packaging sectors. Such physical assets secure the raw material ecosystem needed for bio-composites. Stakeholders in the market can now rely on established industrial hubs for scalable sourcing.
Key Findings in Chitosan Market
| Market Forecast (2034) | US$ 8.6 billion |
| CAGR | 11.8% |
| Largest Region (2025) | Asia Pacific (46.58%) |
| By Source | Shrimps (64.83%) |
| By Application | Water Treatment (38%) |
| Top Drivers |
|
| Top Trends |
|
| Top Challenges |
|
Premium Fungal Grade Valuation At US$ 273 Reshapes Procurement Strategies For Buyers
Q4 2025 pricing data lists standard wholesale prices at US$ 67.00 per kg. Marine-sourced medical grades trade at US$ 188.00 per kg while ultra-pure fungal medical grades hit US$ 273.00 per kg. Food-grade marine options cost US$ 78.00 per kg versus US$ 94.00 per kg for fungal types. Buyers within the Chitosan market must account for these distinct price tiers. Valuation is heavily dependent on the source origin and purity level.
Industrial applications offer lower entry points for bulk procurement. Bulk industrial grades are listed at US$ 62.00 per kg and quaternary grades trade at US$ 50.00 per kg. US export data from 2024 shows a price floor of US$ 102.70 per kg and a ceiling of US$ 151.17 per kg. Orders exceeding 200 kg typically trigger volume discounts. Procurement teams navigating the Chitosan market can leverage these price breaks to optimize operational costs.
Revenue Growth And US$ 140 Million Investment Signal Aggressive Commercial Landscape Maturity
Primex demonstrated strong performance by selling 5,800 metric tons in 2024 to generate US$ 78.4 million in revenue. Qingdao Yunzhou Biochemistry moved 5,100 metric tons achieving US$ 112.6 million in total revenue. Leading players are rapidly consolidating power and expanding their financial footprints. Such robust revenue figures indicate a transition toward a mature phase for the Chitosan market. Market leaders are successfully converting production capacity into tangible financial gains.
Investment activity in 2025 further validates the sector's trajectory. Tidal Vision raised US$ 140 million in Series B financing in February 2025. The company reached a post-money valuation of US$ 650 million following the round. Capital from the raise is allocated to build 3 new facilities in Europe, Texas, and Ohio. Venture capital is fueling a race for infrastructure dominance within the market.
Superior Wound Healing Rates In 2024 Trials Accelerate Medical Device Market Adoption
A Phase I trial posted in July 2024 enrolled 20 patients for periodontal studies while a September 2025 study targets 500 participants for skin quality. The "Effectivity of Chitosan Covered Gauze" study is scheduled for primary completion in March 2025. Clinical validation drives the medical segment of the Chitosan market forward. Ongoing trials provide the necessary data to support regulatory filings for new devices.
Quantitative results from wound care studies highlight significant efficacy. Diabetic foot ulcer trials with 30 patients showed improved median wound scores of 20 points versus 24 points for placebos. Treated groups demonstrated a 4.62-fold higher likelihood of achieving 75% wound closure. Over 60 US biotech firms integrated the material into drug delivery pipelines in 2024. Such efficacy data compels medical manufacturers to adopt solutions from the Chitosan market.
Hydrogel Patent Surge and Nanotech Innovation Fuel Rapid Pharmaceutical Product Pipeline Commercialization
Researchers published 173 patent documents regarding hydrogel-based bioinks between 2013 and 2024. India published Patent Application No. 202441021559 A in March 2024 covering cavity disinfection. July 2024 alone saw 353 scientific papers discussing ascorbic acid combinations. Intense R&D activity fuels the evolution of the Chitosan market. Intellectual property generation is creating a moat for technology-driven companies.
Commercialization follows these scientific breakthroughs closely. Iterro Life Sciences launched trū Chitosan for inhaled drug delivery in July 2025. Seawin Biotech now produces pharmaceutical oligosaccharides under 2,000 Daltons with a deacetylation degree of 85 or higher. Precise specifications allow for the creation of advanced therapeutics. Innovation in molecular engineering is opening new high-value niches within the Chitosan market.
Municipal Projects Adopting Bio Flocculants Mandate Strict Heavy Metal Compliance Standards Globally
Approximately 48% of new municipal water treatment projects initiated in the US in 2024 integrated bio-based solutions. Arab Contractors signed contracts for 6 wastewater treatment plants in Côte d'Ivoire in September 2024. Fraunhofer introduced the "LaChiPur" functionalized flocculant in May 2024. Infrastructure demands are reshaping the industrial requirements of the Chitosan market. Large-scale adoption relies on the shift away from synthetic coagulants.
Operational standards for water treatment grades have become increasingly stringent. Viscosity standards for 2024 sit between 200 cP and 800 cP. Premium filtration grades must adhere to a lead limit below 2 ppm and an arsenic limit under 1 ppm. Suppliers must meet these strict technical benchmarks to compete for utility tenders. Compliance is now a key differentiator in the water treatment segment of the Chitosan market.
New Bio Stimulant Approvals In Americas Empower Agrochemical Firms To Expand Portfolios
Tidal Grow received approval for its Spectra product on California crops in August 2025. The company previously launched GENBOOST in Canada during February 2025. Eden Biotech also introduced a new line of bio-fertilizers in 2024. North American regulatory approvals are expanding the agricultural sector of the Chitosan market. Agrochemical firms are leveraging these green lights to launch sustainable product lines.
South American regulators have formalized the status of biopolymers in pest management. Brazil listed the material under Active Ingredient Code Q06 via Normative Instruction No. 339/24 in late 2024. Normative Instruction No. 338/24 simultaneously updated criteria for clinical dossiers. Latin American legal frameworks now support broad agrochemical adoption. Regulatory clarity allows multinational companies to scale sales within the Chitosan market.
Health Canada Approvals and Precise Standards Reduce Barriers For Food Preservation Entries
Health Canada authorized the use of mushroom-derived preservatives on May 30, 2024. Approved usage levels range from a minimum of 150 ppm to a maximum of 1,500 ppm. Such approvals define the food safety parameters of the Chitosan market. Regulatory bodies are establishing clear lanes for utilizing alternative preservatives.
Technical requirements for this approval are specific. The material must have a molecular weight between 90 kDa and 120 kDa. Deacetylation degrees must not fall below 80. Food and beverage manufacturers utilize these clear guidelines to develop safe products. Harmonized standards facilitate faster product launches in the Chitosan market.
Clean Beauty Trends and Logistics Data Guide Strategic Import Decisions For Retailers
Greenitio launched the vegan Chitobela biopolymer in February 2024 while ChitoCare won a 2024 Tatler Beauty Award. High-quality cosmetic grades require solubility greater than 98% and ash content below 1%. Water-soluble fungal grades trade at US$ 46.00 per kg. The "Clean Beauty" movement drives significant value in the Chitosan market. Brands are prioritizing vegan and high-purity ingredients to meet consumer expectations.
Global trade flows reflect high demand. The US exported 7,800 metric tons and received 251 shipments in 2024 while Canada imported 1,100 metric tons. TomTex targets a US$ 500 billion leather industry with new materials. International shipping adds US$ 2.00 to US$ 5.00 per kg with lead times of 2 to 12 weeks. Compliance checks use CAS 9012-76-4. Logistics planning is critical for success in the global Chitosan market.
Tailor This Report to Your Specific Business Needs: https://www.astuteanalytica.com/ask-for-customization/chitosan-market
Chitosan Market Key Players:
- Primex EHF
- Heppe Medical Chitosan GmbH
- Meron Group
- KitoZyme SA
- Golden-Shell Pharmaceutical Co. Ltd.
- FMC Corporation
- Agra Tech, Inc.
- Axio Biosolutions Pvt Ltd
- Marshall Marine Products
- Other Prominent Players
Key Market Segmentation:
By Source
- Shrimps
- Prawns
- Crabs
- Other Sources
By Application
- Water treatment
- Cosmetics
- Pharmaceutical and Biomedical
- Food and Beverage
- Other Applications
By Region
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- South America
Want Clarity on Report Coverage? Schedule a Quick Demo Call: https://www.astuteanalytica.com/report-walkthrough/chitosan-market
About Astute Analytica
Astute Analytica is a global market research and advisory firm providing data-driven insights across industries such as technology, healthcare, chemicals, semiconductors, FMCG, and more. We publish multiple reports daily, equipping businesses with the intelligence they need to navigate market trends, emerging opportunities, competitive landscapes, and technological advancements.
With a team of experienced business analysts, economists, and industry experts, we deliver accurate, in-depth, and actionable research tailored to meet the strategic needs of our clients. At Astute Analytica, our clients come first, and we are committed to delivering cost-effective, high-value research solutions that drive success in an evolving marketplace.
Contact Us:
Astute Analytica
Phone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World)
For Sales Enquiries: sales@astuteanalytica.com
Website: https://www.astuteanalytica.com/
Follow us on: LinkedIn | Twitter | YouTube
